TwoStep Therapeutics Secures $62.5 Million Series A and FDA Clearance for TS-104 Phase 1 Trial TwoStep Therapeutics, a biotechnology company developing multi-specific targeted therapies for solid tumors, has announced two…
Lotus Neuro Launches to Advance Focused Ultrasound Drug Delivery for Neurological Diseases Lotus Neuro, a clinical-stage biotechnology company focused on combining focused ultrasound with therapeutic medicines to address focal neurological…
Crossbow Therapeutics Doses First Patient in Phase 1 Trial of CBX-663 for Multiple Cancers Crossbow Therapeutics, Inc., a biotechnology company developing targeted antibody therapies designed to address a broad range…
Gilead Sciences Opens New Research Center in Foster City to Accelerate Biomedical Innovation Gilead Sciences, Inc. (Nasdaq: GILD) has officially opened a new 182,000-square-foot Research Center at its headquarters in…
Foot Levelers Announces First-Ever Founder’s Edition PracticeXcelerator Workshop for Chiropractors Foot Levelers, a global leader in custom stabilizing orthotics, has announced its first-ever Founder’s Edition event, an expanded educational and…
restor3d Launches MyFit Digital Suite to Enhance Personalized Orthopedic Patient Experience restor3d, a leader in personalized 3D-printed orthopedic solutions, has announced the launch of MyFit by restor3d Digital Suite, a…
Nanochon Treats First Patient in First-in-Human Clinical Study of Chondrograft for Knee Cartilage Defects Nanochon, a medical device company developing innovative solutions for cartilage repair, has announced the successful treatment…
IVI RMA North America Welcomes Reproductive Endocrinologist Dr. Blake Vessa to RMA New Jersey IVI RMA North America, a leader in fertility care and assisted reproductive medicine, has announced the…
Sarepta Therapeutics Announces 25 Recipients of Route 79 Duchenne Scholarship Program for 2026-2027 Sarepta Therapeutics, Inc. (NASDAQ: SRPT), a company focused on precision genetic medicine for rare diseases, has announced…
Mirum Pharmaceuticals Appoints Rob Myers, M.D. as Chief Medical Officer to Lead Global Medical and Clinical Development Mirum Pharmaceuticals, Inc. (Nasdaq: MIRM), a rare disease-focused pharmaceutical company developing medicines for…
Encoded Therapeutics Reports Durable Seizure Reduction and Neurodevelopmental Gains With ETX101 in Dravet Syndrome Encoded Therapeutics, Inc., a clinical-stage biotechnology company focused on developing precision genetic medicines for severe neurological…
Endeavor BioMedicines Reports Positive Quantitative Imaging Results for Taladegib in Idiopathic Pulmonary Fibrosis Endeavor BioMedicines, a clinical-stage biotechnology company focused on developing medicines with the potential to deliver transformational benefits…